Literature DB >> 17000123

Antibiotic resistance in Propionibacterium acnes. Microbiological and clinical aspects.

Carl Erik Nord1, Cristina Oprica.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17000123     DOI: 10.1016/j.anaerobe.2006.08.001

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


× No keyword cloud information.
  15 in total

Review 1.  Antianaerobic antimicrobials: spectrum and susceptibility testing.

Authors:  Itzhak Brook; Hannah M Wexler; Ellie J C Goldstein
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

2.  Propionibacterium acnes infection as an occult cause of postoperative shoulder pain: a case series.

Authors:  Peter J Millett; Yi-Meng Yen; Connie S Price; Marilee P Horan; Olivier A van der Meijden; Florian Elser
Journal:  Clin Orthop Relat Res       Date:  2011-01-15       Impact factor: 4.176

3.  Role of rifampin against Propionibacterium acnes biofilm in vitro and in an experimental foreign-body infection model.

Authors:  Ulrika Furustrand Tafin; Stéphane Corvec; Bertrand Betrisey; Werner Zimmerli; Andrej Trampuz
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

4.  Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris.

Authors:  Teruaki Nakatsuji; Mandy C Kao; Jia-You Fang; Christos C Zouboulis; Liangfang Zhang; Richard L Gallo; Chun-Ming Huang
Journal:  J Invest Dermatol       Date:  2009-04-23       Impact factor: 8.551

5.  Antimicrobial activity of enterocins from Enterococcus faecalis SL-5 against Propionibacterium acnes, the causative agent in acne vulgaris, and its therapeutic effect.

Authors:  Bong Seon Kang; Jae-Gu Seo; Gwa-Su Lee; Jung-Hwa Kim; Sei Yeon Kim; Ye Won Han; Hoon Kang; Hyung Ok Kim; Ji Hwan Rhee; Myung-Jun Chung; Young Min Park
Journal:  J Microbiol       Date:  2009-02-20       Impact factor: 3.422

6.  Antibodies elicited by inactivated propionibacterium acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris.

Authors:  Teruaki Nakatsuji; Yu-Tsueng Liu; Cheng-Po Huang; Christos C Zoubouis; Richard L Gallo; Chun-Ming Huang
Journal:  J Invest Dermatol       Date:  2008-05-08       Impact factor: 8.551

7.  Rosmarinus officinalis extract suppresses Propionibacterium acnes-induced inflammatory responses.

Authors:  Tsung-Hsien Tsai; Lu-Te Chuang; Tsung-Jung Lien; Yau-Rong Liing; Wei-Yu Chen; Po-Jung Tsai
Journal:  J Med Food       Date:  2013-03-20       Impact factor: 2.786

8.  Survey of shoulder arthroplasty surgeons' methods for infection avoidance of Propionibacterium.

Authors:  Stephen A Parada; K Aaron Shaw; Josef K Eichinger; Monica J Stadecker; Laurence D Higgins; Jon J P Warner
Journal:  J Orthop       Date:  2018-02-02

Review 9.  Bacteriophages infecting Propionibacterium acnes.

Authors:  Holger Brüggemann; Rolf Lood
Journal:  Biomed Res Int       Date:  2013-04-11       Impact factor: 3.411

10.  Inducible Siphoviruses in superficial and deep tissue isolates of Propionibacterium acnes.

Authors:  Rolf Lood; Matthias Mörgelin; Anna Holmberg; Magnus Rasmussen; Mattias Collin
Journal:  BMC Microbiol       Date:  2008-08-15       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.